JP2012102100A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012102100A5 JP2012102100A5 JP2011247036A JP2011247036A JP2012102100A5 JP 2012102100 A5 JP2012102100 A5 JP 2012102100A5 JP 2011247036 A JP2011247036 A JP 2011247036A JP 2011247036 A JP2011247036 A JP 2011247036A JP 2012102100 A5 JP2012102100 A5 JP 2012102100A5
- Authority
- JP
- Japan
- Prior art keywords
- antagonist
- hepatitis
- antibody
- treatment
- specifically recognizes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102100025137 Early activation antigen CD69 Human genes 0.000 claims 9
- 101000934374 Homo sapiens Early activation antigen CD69 Proteins 0.000 claims 9
- 239000005557 antagonist Substances 0.000 claims 6
- 208000006454 hepatitis Diseases 0.000 claims 6
- 231100000283 hepatitis Toxicity 0.000 claims 5
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 claims 2
- 108010082126 Alanine transaminase Proteins 0.000 claims 2
- 108010003415 Aspartate Aminotransferases Proteins 0.000 claims 1
- 102000004625 Aspartate Aminotransferases Human genes 0.000 claims 1
- 231100000354 acute hepatitis Toxicity 0.000 claims 1
- 208000024891 symptom Diseases 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12/945,153 | 2010-11-12 | ||
| US12/945,153 US8440195B2 (en) | 2010-11-12 | 2010-11-12 | Inhibition of CD69 for treatment of inflammatory conditions |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012102100A JP2012102100A (ja) | 2012-05-31 |
| JP2012102100A5 true JP2012102100A5 (enExample) | 2015-01-22 |
| JP5938876B2 JP5938876B2 (ja) | 2016-06-22 |
Family
ID=46047944
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011247036A Active JP5938876B2 (ja) | 2010-11-12 | 2011-11-11 | Ｃｄ６９アンタゴニストを含む肝炎治療用組成物 |
Country Status (2)
| Country | Link |
|---|---|
| US (2) | US8440195B2 (enExample) |
| JP (1) | JP5938876B2 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8440195B2 (en) | 2010-11-12 | 2013-05-14 | National University Corporation Chiba University | Inhibition of CD69 for treatment of inflammatory conditions |
| JP6570023B2 (ja) * | 2016-10-21 | 2019-09-04 | 国立大学法人山口大学 | Ｃｄ６９アンタゴニストを含む劇症型急性肺炎治療用組成物 |
| JP6944701B2 (ja) * | 2016-10-21 | 2021-10-06 | 国立大学法人山口大学 | ＣＤ１１ｂアンタゴニストを含む劇症型急性肺炎治療用組成物 |
| CN120569191A (zh) | 2022-11-23 | 2025-08-29 | 乔治亚大学研究基金公司 | 用于增加免疫应答的组合物及其使用方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6794132B2 (en) * | 1999-10-02 | 2004-09-21 | Biosite, Inc. | Human antibodies |
| DK1257292T3 (da) * | 2000-02-21 | 2011-07-18 | Merck Serono Sa | Anvendelse af IL-18-inhibitorer |
| EP2347767A3 (en) * | 2003-01-31 | 2013-06-12 | Albor Biologics, Inc. | Immune regulation based on the targeting of early activation molecules |
| WO2004103403A1 (ja) * | 2003-05-23 | 2004-12-02 | Immuno-Biological Laboratories Co., Ltd. | 免疫担当細胞活性化阻害剤およびその用途 |
| NZ543654A (en) * | 2003-05-23 | 2009-05-31 | Wyeth Corp | GITR ligand and GITR ligand-related molecules and antibodies and uses thereof |
| AR053579A1 (es) * | 2005-04-15 | 2007-05-09 | Genentech Inc | Tratamiento de la enfermedad inflamatoria intestinal (eii) |
| JP2007022993A (ja) * | 2005-07-20 | 2007-02-01 | Chiba Univ | アレルギー性喘息の治療薬 |
| US8440195B2 (en) | 2010-11-12 | 2013-05-14 | National University Corporation Chiba University | Inhibition of CD69 for treatment of inflammatory conditions |
-
2010
- 2010-11-12 US US12/945,153 patent/US8440195B2/en active Active
-
2011
- 2011-11-11 JP JP2011247036A patent/JP5938876B2/ja active Active
-
2013
- 2013-04-16 US US13/863,439 patent/US10449252B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013546230A5 (enExample) | ||
| IL254422A0 (en) | Subsituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating hcv infections | |
| EA201101117A1 (ru) | Ингибиторы дпп-4 для лечения диабета у детей | |
| JP2014530840A5 (enExample) | ||
| JP2012171428A5 (enExample) | ||
| JP2012046524A5 (enExample) | ||
| WO2010036395A3 (en) | Treatment of organophosphate exposure with tetrahydroindolone arylpiperazine compounds | |
| EP2889371A4 (en) | BACTEROIDES CECT 7771 AND USE THEREOF IN THE PREVENTION AND TREATMENT OF OVERWEIGHT, FAT SUPPORT AND METABOLIC AND IMMUNOLOGICAL CHANGES | |
| JP2013540852A5 (enExample) | ||
| JP2008056926A5 (enExample) | ||
| AR089711A1 (es) | Inhibidores del virus de hepatitis c | |
| JP2015504870A5 (enExample) | ||
| JP2013522425A5 (enExample) | ||
| HK1199640A1 (en) | Heteroaryl hydroxamic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease | |
| EP2521453A4 (en) | METHOD AND COMPOSITIONS FOR TREATING MIGRAINE | |
| JP2015526577A5 (enExample) | ||
| JP2012102100A5 (enExample) | ||
| TN2011000204A1 (en) | Cycloundecadepsipeptide compounds and use of said compounds as a medicament | |
| IL211810A0 (en) | Therapeutic regimen comprising peg- interferon, ribavirin and vx-950 for the treatment of hepatitis | |
| JP2011510778A5 (enExample) | ||
| EA201401286A1 (ru) | Композиции и способы для лечения синдрома раздраженной толстой кишки с помощью 5-аминосалицилата | |
| AR090544A1 (es) | Metodo para tratar selectivamente a un sujeto que tenga cancer | |
| MX2013003903A (es) | Nuevos tratamientos de infeccion por el virus de hepatitis c. | |
| RU2008128156A (ru) | Способ прогнозирования эффективности лечения бронхиальной астмы | |
| MX370061B (es) | Uso de antagonistas del par-1 para prevenir y/o tratar condiciones patologicas funcionales pelviperineales. |